Literature DB >> 18641299

Type I IFN-induced, NKT cell-mediated negative control of CD8 T cell priming by dendritic cells.

Petra Bochtler1, Andrea Kröger, Reinhold Schirmbeck, Jörg Reimann.   

Abstract

We investigated the negative effect of type I IFN (IFN-I) on the priming of specific CD8 T cell immunity. Priming of murine CD8 T cells is down-modulated if Ag is codelivered with IFN-I-inducing polyinosinic:polycytidylic acid (pI/C) that induces (NK cell- and T/B cell-independent) acute changes in the composition and surface phenotype of dendritic cells (DC). In wild-type but not IFN-I receptor-deficient mice, pI/C reduces the plasmacytoid DC but expands the CD8(+) conventional DC (cDC) population and up-regulates surface expression of activation-associated (CD69, BST2), MHC (class I/II), costimulator (CD40, CD80/CD86), and coinhibitor (PD-L1/L2) molecules by cDC. Naive T cells are efficiently primed in vitro by IFN-I-stimulated CD8 cDC (the key APC involved in CD8 T cell priming) although these DC produced less IL-12 p40 and IL-6. pI/C (IFN-I)-mediated down modulation of CD8 T cell priming in vivo was not observed in NKT cell-deficient CD1d(-/-) mice. CD8 cDC from pI/C-treated mice inefficiently stimulated IFN-gamma, IL-4, and IL-2 responses of NKT cells. In vitro, CD8 cDC that had activated NKT cells in the presence of IFN-I primed CD8 T cells that produced less IFN-gamma but more IL-10. The described immunosuppressive effect of IFN-I thus involves an NKT cell-mediated change in the phenotype of CD8 cDC that favors priming of IL-10-producing CD8 T cells. In the presence of IFN-I, NKT cells hence impair the competence of CD8 cDC to prime proinflammatory CD8 T cell responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18641299     DOI: 10.4049/jimmunol.181.3.1633

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Treatment of SIV-infected sooty mangabeys with a type-I IFN agonist results in decreased virus replication without inducing hyperimmune activation.

Authors:  Thomas H Vanderford; Chloe Slichter; Kenneth A Rogers; Benton O Lawson; Rend Obaede; James Else; Francois Villinger; Steven E Bosinger; Guido Silvestri
Journal:  Blood       Date:  2012-05-01       Impact factor: 22.113

2.  TLR3-stimulated dendritic cells up-regulate B7-H1 expression and influence the magnitude of CD8 T cell responses to tumor vaccination.

Authors:  Vesna Pulko; Xin Liu; Christopher J Krco; Kimberley J Harris; Xavier Frigola; Eugene D Kwon; Haidong Dong
Journal:  J Immunol       Date:  2009-08-26       Impact factor: 5.422

3.  The Regulation of Immune Responses by DC Derived Type I IFN.

Authors:  Dennis Ng; Jennifer L Gommerman
Journal:  Front Immunol       Date:  2013-04-22       Impact factor: 7.561

Review 4.  Immune Checkpoint Inhibitors to Treat Malignant Lymphomas.

Authors:  Magdalena Witkowska; Piotr Smolewski
Journal:  J Immunol Res       Date:  2018-04-11       Impact factor: 4.818

Review 5.  Cross Talk Between Natural Killer T and Dendritic Cells and Its Impact on T Cell Responses in Infections.

Authors:  Lei Zhao; Xi Yang
Journal:  Front Immunol       Date:  2022-02-03       Impact factor: 7.561

6.  Parity-induced changes to mammary epithelial cells control NKT cell expansion and mammary oncogenesis.

Authors:  Amritha Varshini Hanasoge Somasundara; Matthew A Moss; Mary J Feigman; Chen Chen; Samantha L Cyrill; Michael F Ciccone; Marygrace C Trousdell; Macy Vollbrecht; Siran Li; Jude Kendall; Semir Beyaz; John E Wilkinson; Camila O Dos Santos
Journal:  Cell Rep       Date:  2021-12-07       Impact factor: 9.995

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.